January 07, 2026-- NeuraLight, the leader in developing precision biomarkers for neurology, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with standard ...
PALOMA study is one of the largest longitudinal studies using eye-movement biomarkers in patients with Parkinson’s diseaseNEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--NeuraLight, the leader in ...
Jesy Nelson noticed worrying signs about her twin daughters’ Ocean Jade and Story Monroe’s health, weeks before they were ...
MedPage Today on MSN
Eye Issues Common With ANCA-Associated Vasculitis
Conjunctivitis or episcleritis and scleritis comprised the most common eye manifestations, while cataracts (11.7%) and visual ...
Three-Way Collaboration to Bring Innovative Oral Mucosal Stem Cell Therapy with U.S. GMP Manufacturing and Commercialization Infrastructure to Patients Seeking Treatment for Non-healing Diabetic Foot ...
News-Medical.Net on MSN
Research breakthrough could provide a new, non-invasive way to assess retinal health
For the first time, an international research team led by Nanyang Technological University, Singapore (NTU Singapore) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback